HORIBA announces plans to build a new global headquarters on the site of its current head office in Kisshoin, Minami-ku, Kyoto. Construction began in December 2025, and completion is planned for January 2028.
Sirio Pharma (Sirio), a global nutraceutical CDMO, has collaborated with ingredient provider OmniActive Health Technologies (OmniActive) to launch a first-in-market soft chew lutein supplement.
Cold Chain Technologies (CCT) has announced a strategic partnership with Gobi Technologies to give customers access to a greater range of temperature-controlled containers for Cell and Gene Therapies.
Calla Lily Clinical Care, a women’s health-focused medtech company, and Merck, a science and technology company, have entered a strategic collaboration to support the continued development of Callavid, a platform for intravaginal drug delivery.
Synthace, has announced a collaboration with Charles River Laboratories International (Charles River), a global drug discovery, development, testing, and manufacturing solutions provider.
Visby Medical, an innovator in at-home PCR testing of infectious diseases, has announced a strategic collaboration with Watchmaker Genomics, to develop next-generation diagnostic tests for respiratory pathogen detection in the at-home setting.
Evogene and Shanghai Lishan Biopharmaceuticals (Lishan Biotech) have announced that Biomica, Evogene’s subsidiary, and Lishan Biotech entered into an exclusive worldwide licensing agreement for BMC128 (designated as LS-LBP-002 by Lishan Biotech).
IMed Group, a provider of regulatory consultancy services to the global medical and health technology industry, has announced the appointment of Spencer Keegan as talent acquisition manager.
Vetter, a pharmaceutical service provider for the production of injectable drugs, has confirmed its plans to build a production facility in the Saarland region of southwest Germany.
